Comparative analysis of QS3D versus droplet digital PCR for quantitative measures of EGFR T790M mutation from identical plasma

Comparative analysis of QS3D versus droplet digital PCR for quantitative measures of EGFR T790M mutation from identical plasma

Objectives: The capacity of QuantStudio™ 3D (QS3D) and droplet digital PCR (dPCR) for the detection of plasma Epidermal Growth Factor Receptor (EGFR) mutations have been widely reported. Few comparative studies on the quantitative test of the identical DNA material, however, are carried out. Here we...

Full description

Bibliographic Details
Main Authors:	Qiaomei Guo, Lin Wang, Xiaohui Liang, Mingna Zhao, Xia Huang, Wanxing Xu, Jiatao Lou, Lihua Qiao
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	Heliyon
Subjects:	cfDNA Concordance Digital PCR Mutation abundance T790M
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844022026275

Similar Items

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
by: Ivonne Nel, et al.
Published: (2023-12-01)

Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations
by: Durgut S, et al.
Published: (2024-03-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

The Polemic Diagnostic Role of <i>TP53</i> Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
by: M. Carmen Garrido-Navas, et al.
Published: (2020-11-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
by: Yu Zhang, et al.
Published: (2024-03-01)

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
by: Javier Oliver, et al.
Published: (2023-06-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Simultaneous Detection of the T790M and L858R Mutations in the <i>EGFR</i> Gene by Oligoribonucleotide Interference-PCR
by: Keisuke Baba, et al.
Published: (2019-08-01)

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
by: José Manuel González de Aledo-Castillo, et al.
Published: (2021-07-01)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
by: Christi M. J. Steendam, et al.
Published: (2020-10-01)

The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare
by: Weiting Li, et al.
Published: (2022-07-01)

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas
by: Ramón Diez-Feijóo, et al.
Published: (2024-01-01)

Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
by: Zihao Liu, et al.
Published: (2024-03-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

<i>ANK2</i> Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
by: Johannes J. Schabort, et al.
Published: (2020-11-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Neutrophil extracellular traps in stored canine red blood cell units
by: Erin R. McQuinn, et al.
Published: (2020-09-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
by: Stine H. Kresse, et al.
Published: (2023-09-01)

Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions
by: Kuo-Ping Chiu, et al.
Published: (2019-08-01)

Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
by: Hui Zhang, et al.
Published: (2023-01-01)

The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors
by: Ikei S. Kobayashi, MD, PhD, et al.
Published: (2024-01-01)

A Fully Integrated Microfluidic Device with Immobilized Dyes for Simultaneous Detection of Cell-Free DNA and Histones from Plasma Using Dehydrated Agarose Gates
by: Shadi Shahriari, et al.
Published: (2024-03-01)

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
by: Stefania Crucitta, et al.
Published: (2024-01-01)

Effect of acute moderate-intensity cycling on cfDNA levels considering menstrual cycle phases
by: Akemi Sawai, et al.
Published: (2024-01-01)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
by: Emma Sandberg, et al.
Published: (2024-01-01)

Rapid and Efficient Extraction of Cell-Free DNA Using Homobifunctional Crosslinkers
by: HyeonAh Seong, et al.
Published: (2022-08-01)

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems
by: Lijing Zhang, et al.
Published: (2023-10-01)

Cell-Free DNA in Plasma and Serum Indicates Disease Severity and Prognosis in Blunt Trauma Patients
by: Inga Trulson, et al.
Published: (2023-03-01)

Neutrophil-dependent Mitochondrial DNA Release Associated With Extracellular Trap Formation in Inflammatory Bowel Disease
by: Broc Drury, et al.
Published: (2023-01-01)

Rebiopsy with Thoracoscopy under Local Anesthesia for the Detection of EGFR T790M Mutation
by: Asako Matsuda, et al.
Published: (2019-12-01)

Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation
by: Noelia García-Fernández, et al.
Published: (2022-12-01)

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy
by: Martin Filipits, et al.
Published: (2023-07-01)

Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
by: Caichen Li, et al.
Published: (2020-03-01)

Profile of Exon 20 T790M Mutation Incidence Rate with Plasma ctDNA in Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
by: Muhammad Harbi Praditya, et al.
Published: (2023-01-01)